Prognostic factors in localized soft-tissue sarcomas. 2003

Esra Kaytan, and Fulya Yaman, and Rusen Cosar, and Yesim Eralp, and Pnar Saip, and Emin Darendeliler
Department of Radiation Oncology, University of Istanbul, Institute of Oncology, Istanbul, Turkey.

The prognostic factors associated with local failure and overall survival and the effect of radiotherapy were determined in 77 patients with localized (extremity and nonextremity) operable soft-tissue sarcoma. There were 52 male and 25 female patients; median age was 50 years (range: 15-83). Histologic grade of the tumors was as follows: low-intermediate grade in 32 cases and high grade in 29 cases. The primary tumors were treated by marginal resection (20 patients), wide resection (52 patients), and radical resection (5 patients). Adjuvant radiotherapy was applied to 50 (65%) patients. The 5-year local recurrence-free survival rate was 70.6%. Treatment with adjuvant radiotherapy and development of metastases were the significant prognostic factors associated with local recurrence. Radiotherapy was more effective in patients with tumors 10 cm or larger, marginally resected, extremity located, and high grades. The overall survival rate was 64.4% at 5 years. Significant adverse prognostic factors were high grade tumors, presence of local recurrence, and development of metastases in univariate analyses. Development of metastases and old age were the only adverse prognostic factors by multivariate analysis. The best 5-year survival rate was obtained in female patients younger than 50 years (90%). The present study demonstrated the importance of adjuvant radiotherapy and development of metastases as prognostic factors for local control. Again, development of metastases and age were the most important prognostic factors in operable soft-tissue sarcomas.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Esra Kaytan, and Fulya Yaman, and Rusen Cosar, and Yesim Eralp, and Pnar Saip, and Emin Darendeliler
March 1991, Archives of surgery (Chicago, Ill. : 1960),
Esra Kaytan, and Fulya Yaman, and Rusen Cosar, and Yesim Eralp, and Pnar Saip, and Emin Darendeliler
January 2005, Anticancer research,
Esra Kaytan, and Fulya Yaman, and Rusen Cosar, and Yesim Eralp, and Pnar Saip, and Emin Darendeliler
May 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Esra Kaytan, and Fulya Yaman, and Rusen Cosar, and Yesim Eralp, and Pnar Saip, and Emin Darendeliler
January 1996, British journal of plastic surgery,
Esra Kaytan, and Fulya Yaman, and Rusen Cosar, and Yesim Eralp, and Pnar Saip, and Emin Darendeliler
July 1988, Gan to kagaku ryoho. Cancer & chemotherapy,
Esra Kaytan, and Fulya Yaman, and Rusen Cosar, and Yesim Eralp, and Pnar Saip, and Emin Darendeliler
November 1998, European journal of cancer (Oxford, England : 1990),
Esra Kaytan, and Fulya Yaman, and Rusen Cosar, and Yesim Eralp, and Pnar Saip, and Emin Darendeliler
August 2000, Cancer,
Esra Kaytan, and Fulya Yaman, and Rusen Cosar, and Yesim Eralp, and Pnar Saip, and Emin Darendeliler
March 2005, Chest,
Esra Kaytan, and Fulya Yaman, and Rusen Cosar, and Yesim Eralp, and Pnar Saip, and Emin Darendeliler
February 2008, Expert review of anticancer therapy,
Esra Kaytan, and Fulya Yaman, and Rusen Cosar, and Yesim Eralp, and Pnar Saip, and Emin Darendeliler
September 1988, Cancer,
Copied contents to your clipboard!